ACZ885 for the Treatment of Abdominal Aortic Aneurysm
Status:
Terminated
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This study was designed to assess the safety, tolerability and efficacy of ACZ885 on
aneurysmal growth rate in subjects with abdominal aortic aneurysms (AAA). The purpose of the
study was to provide data to enable decisions regarding the further development of ACZ885 for
subjects with abdominal aortic aneurysms. The design of this study addressed the primary
objective of evaluating the change in aneurysmal size in subjects with AAA as a result of
treatment with ACZ885.